Shares of CVS Health (CVS) are doing well Monday, but have struggled for most of 2016, falling almost 15%. Investors are hoping the company's earnings results on Tuesday will help reverse their fortunes.

The stock's being hurt by the company's perceived weakness tied to its pharmacy business, TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said from the floor of the New York Stock Exchange Monday.

So if management tells investors that its pharmacy isn't doing that bad and that the front of the store -- its convenience business -- is doing well, then investors should take that as a big positive.

Unfortunately for CVS, it's being viewed as a health care play, a sector that is under enormous pressure, rather than a drug store play, Cramer explained.

The stock would be favorably viewed and likely one investors want to buy if the CEO would outline a non-health care related vision for the business, Cramer concluded.

Analysts expect the company to earn $1.57 per share on $45.29 billion in revenue.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

2 More Reasons to Sell All Your Stocks and Run Away

2 More Reasons to Sell All Your Stocks and Run Away

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast